NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News $62.03 +0.50 (+0.81%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$62.06 +0.03 (+0.06%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BBP alerts:Sign Up Key Stats Today's Range$60.91▼$62.0350-Day Range$55.23▼$64.0052-Week Range$48.65▼$69.12Volume2,139 shsAverage Volume2,803 shsMarket Capitalization$24.81 millionAssets Under Management$24.65 millionDividend YieldN/ANet Expense Ratio0.79%Aggregate RatingModerate Buy ETF Overview The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus. Read More Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.56%0.51%0.53%Other Expenses0.00%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%Net Expense0.79%0.60%0.63%0.58%0.60% Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBP ETF News HeadlinesVirtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.2394December 23, 2024 | msn.comCanadian ETF Comparison Series: FCUQ vs. ZUQ.FDecember 17, 2024 | theglobeandmail.comMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds). | American Alternative (Ad)BBP Virtus LifeSci Biotech Products ETFOctober 9, 2024 | seekingalpha.comVirtus LifeSci Biotech Products ETF (BBP)August 25, 2024 | investing.comVirtus LifeSci Biotech Clinical Trials ETF (BBC)August 16, 2024 | investing.comSee More Headlines BBP ETF - Frequently Asked Questions How have BBP shares performed this year? Virtus LifeSci Biotech Products ETF's stock was trading at $60.02 on January 1st, 2025. Since then, BBP stock has increased by 3.3% and is now trading at $62.03. How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Products ETF investors own include Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY), Gilead Sciences (GILD), Simon Property Group (SPG), Intel (INTC) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings59 Fund Statistics Assets Under Management$24.65 million Average Daily Volume$2.08 thousand Discount/Premium-0.08% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume12 Put Options0 Call Options12 Short Interest6,800 shs Miscellaneous Outstanding Shares400,000Beta0.73 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 BBP HoldingsCRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 2.84%Rhythm Pharmaceuticals (NASDAQ:RYTM)Holding Weight: 2.47%Iovance Biotherapeutics (NASDAQ:IOVA)Holding Weight: 2.41%Moderna (NASDAQ:MRNA)Holding Weight: 2.13%Ardelyx (NASDAQ:ARDX)Holding Weight: 2.11%Ionis Pharmaceuticals (NASDAQ:IONS)Holding Weight: 2.09%Legend Biotech (NASDAQ:LEGN)Holding Weight: 2.06%Ligand Pharmaceuticals (NASDAQ:LGND)Holding Weight: 2.06%BridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 2.05%Agios Pharmaceuticals (NASDAQ:AGIO)Holding Weight: 2.04%Full Holdings DetailsBBP Sector ExposureBBP Industry Exposure This page (NYSEARCA:BBP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
